A Virtual Medical Scribe
Practice medicine free from the time-consuming administrative tasks within the EHR. Tenor is an automated medical scribe that listens to your patient visits via a small microphone in the exam room and creates an accurate patient note in real time. No typing. No dictating. The future is now.
Tenor is a virtual medical scribe powered by artificial intelligence. It listens to each patient interaction to create a complete patient note, in real time.
Tenor’s accurate and concise patient notes incorporate all billing criteria so healthcare providers confidently bill the appropriate amount every time.
Built on cutting-edge deep learning technology, Tenor is trained on real patient/doctor interactions. Over time, Tenor learns to emulate each clinician’s preferences and style.
Mike is the Co-Founder and CEO of Tenor.ai. From a medical family of surgeons, ER docs and nurses, Mike is an experienced entrepreneur who successfully built and sold his first company, Algentis, in the highly regulated human resources and insurance technology space. Inspired by the doctors in his family, Mike was turned on to the problem of physician burnout related to the time consuming administrative tasks that surround their patient interactions. Mike holds an MBA from Stanford University and an undergraduate degree in Finance and International Business from Georgetown University.
Sheraz is a seasoned leader with over 20 years of experience in new product and business development, strategy consulting, and data science including leadership positions at Google and American Express. He has extensive machine learning experience spanning data preparation and exploration, unsupervised and supervised machine learning, neural networks and statistical analysis. Sheraz holds masters degrees in Information and Data Science from Berkeley and Statistics and Operations Research from Princeton and an undergraduate degree in Industrial Engineering from the University of Manitoba.
Are you a medical practice or clinician who wants to be part of our initial launch?
Subscribe To Our Newsletter
Join our mailing list to receive the latest news and updates from our team.